Regeneron Pharmaceuticals
REGN
$982.29
Share price
1.48%
Change (1 day)
31.04%
Change (1 year)
Categories
Market capitalization of Regeneron Pharmaceuticals (REGN)
Market cap: $108.23 Billion
As of May 2024 Regeneron Pharmaceuticals has a market cap of $108.23 Billion. This makes Regeneron Pharmaceuticals the world's 143th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Regeneron Pharmaceuticals from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $108.23 B | 13.11% |
| 2023 | $95.68 B | 21.78% |
| 2022 | $78.57 B | 15.69% |
| 2021 | $67.91 B | 31.74% |
| 2020 | $51.55 B | 24.5% |
| 2019 | $41.40 B | 1.7% |
| 2018 | $40.71 B | 0.79% |
| 2017 | $40.39 B | 4.33% |
| 2016 | $38.71 B | -31.85% |
| 2015 | $56.81 B | 35.19% |
| 2014 | $42.02 B | 53.15% |
| 2013 | $27.43 B | 64.85% |
| 2012 | $16.64 B | 224.35% |
| 2011 | $5.13 B | 74.8% |
| 2010 | $2.93 B | 49.69% |
| 2009 | $1.96 B | 34.11% |
| 2008 | $1.46 B | -23.21% |
| 2007 | $1.90 B | 45.08% |
| 2006 | $1.31 B | 46.27% |
| 2005 | $0.89 B | 74.43% |
| 2004 | $0.51 B | -37.05% |
| 2003 | $0.81 B | -0.78% |
| 2002 | $0.82 B | -33.46% |
| 2001 | $1.23 B |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of Regeneron Pharmaceuticals was reported to be:
$108.23 Billion
$108.23 Billion
$106.03 Billion
$108.23 Billion
$106.65 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $372.16 B | 243.85% | 🇺🇸 USA |
 Novartis NVS | $209.58 B | 93.64% | 🇨🇭 Switzerland |
 Amgen AMGN | $167.61 B | 54.87% | 🇺🇸 USA |
 Sanofi SNY | $122.00 B | 12.73% | 🇫🇷 France |
 Biogen BIIB | $33.57 B | -68.98% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $18.89 B | -82.54% | 🇺🇸 USA |